Healthcare provider profile · identity verified

Jennifer M Langbehn, DO

Family Practice · SAINT JAMES, MN · NPI 1184608671

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	635	113
Eliquis	Apixaban	510	59
Gabapentin	Gabapentin	462	86
Atorvastatin Calcium	Atorvastatin Calcium	420	110
Furosemide	Furosemide	308	75
Warfarin Sodium	Warfarin Sodium	307	27
Lisinopril	Lisinopril	289	82
Pantoprazole Sodium	Pantoprazole Sodium	260	68
Sertraline Hcl	Sertraline Hcl	252	54
Amlodipine Besylate	Amlodipine Besylate	241	65
Potassium Chloride	Potassium Chloride	222	56
Metoprolol Succinate	Metoprolol Succinate	209	53
Metoprolol Tartrate	Metoprolol Tartrate	195	57
Quetiapine Fumarate	Quetiapine Fumarate	169	33
Simvastatin	Simvastatin	165	45
Tramadol Hcl	Tramadol Hcl	164	51
Tamsulosin Hcl	Tamsulosin Hcl	163	40
Omeprazole	Omeprazole	159	58
Losartan Potassium	Losartan Potassium	154	49
Duloxetine Hcl	Duloxetine Hcl	148	31
Ropinirole Hcl	Ropinirole Hcl	140	15
Metformin Hcl	Metformin Hcl	132	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	128	32
Allopurinol	Allopurinol	127	29
Trazodone Hcl	Trazodone Hcl	121	28
Lamotrigine	Lamotrigine	106	14
Donepezil Hcl	Donepezil Hcl	96	17
Venlafaxine Hcl Er	Venlafaxine Hcl	96	18
Spironolactone	Spironolactone	95	28
Carvedilol	Carvedilol	94	27
Hydrochlorothiazide	Hydrochlorothiazide	94	25
Mirtazapine	Mirtazapine	90	24
Oxycodone Hcl	Oxycodone Hcl	90	34
Latanoprost	Latanoprost	89	19
Escitalopram Oxalate	Escitalopram Oxalate	88	21
Rosuvastatin Calcium	Rosuvastatin Calcium	88	29
Levetiracetam	Levetiracetam	87	15
Torsemide	Torsemide	86	25
Memantine Hcl	Memantine Hcl	82	13
Hydroxyzine Hcl	Hydroxyzine Hcl	77	23
Prednisone	Prednisone	77	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	74	suppressed
Xarelto	Rivaroxaban	73	suppressed
Clopidogrel	Clopidogrel Bisulfate	71	16
Citalopram Hbr	Citalopram Hydrobromide	70	17
Shingrix	Varicella-Zoster Ge/As01b/Pf	70	50
Fluticasone Propionate	Fluticasone Propionate	69	25
Aripiprazole	Aripiprazole	65	suppressed
Metformin Hcl Er	Metformin Hcl	62	17
Bupropion Xl	Bupropion Hcl	60	15
Fluoxetine Hcl	Fluoxetine Hcl	59	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	13
Carbidopa-Levodopa	Carbidopa/Levodopa	56	14
Lactulose	Lactulose	56	suppressed
Novolog Flexpen	Insulin Aspart	56	11
Baclofen	Baclofen	53	suppressed
Trulicity	Dulaglutide	52	11
Oxybutynin Chloride Er	Oxybutynin Chloride	51	13
Topiramate	Topiramate	51	suppressed
Famotidine	Famotidine	50	17
Finasteride	Finasteride	50	11
Alendronate Sodium	Alendronate Sodium	49	15
Amitriptyline Hcl	Amitriptyline Hcl	49	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	48	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	12
Methotrexate	Methotrexate Sodium	46	suppressed
Admelog Solostar	Insulin Lispro	44	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	44	suppressed
Hydrocortisone	Hydrocortisone	44	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	40	39
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	suppressed
Midodrine Hcl	Midodrine Hcl	39	13
Humalog Kwikpen U-100	Insulin Lispro	38	11
Pioglitazone Hcl	Pioglitazone Hcl	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Alprazolam	Alprazolam	37	suppressed
Atenolol	Atenolol	37	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	37	12
Valproic Acid	Valproic Acid (As Sodium Salt)	37	suppressed
Insulin Aspart Flexpen	Insulin Aspart	36	12
Insulin Lispro Kwikpen U-100	Insulin Lispro	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	11
Methocarbamol	Methocarbamol	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Nystatin	Nystatin	33	15
Buspirone Hcl	Buspirone Hcl	32	11
Doxycycline Hyclate	Doxycycline Hyclate	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Acetic Acid	Acetic Acid	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	11
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	28	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	27	27
Lovastatin	Lovastatin	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Pregabalin	Pregabalin	25	11
Sucralfate	Sucralfate	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	16
Glimepiride	Glimepiride	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Diltiazem Hcl	Diltiazem Hcl	23	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Sulfasalazine	Sulfasalazine	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Digoxin	Digoxin	21	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	21	14
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	11
Myrbetriq	Mirabegron	20	suppressed
Primidone	Primidone	20	suppressed
Timolol Maleate	Timolol Maleate	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	19	19
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Tetrabenazine	Tetrabenazine	19	suppressed
Creon	Lipase/Protease/Amylase	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Fentanyl	Fentanyl	18	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Metolazone	Metolazone	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Ondansetron Odt	Ondansetron	18	11
Xifaxan	Rifaximin	18	suppressed
Cephalexin	Cephalexin	17	13
Glipizide	Glipizide	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Oxazepam	Oxazepam	17	suppressed
Cefadroxil	Cefadroxil	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Amoxicillin	Amoxicillin	15	11
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Motegrity	Prucalopride Succinate	14	suppressed
Restasis	Cyclosporine	14	suppressed
Cyclosporine	Cyclosporine	13	suppressed
Diazepam	Diazepam	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	13	suppressed
Ozempic	Semaglutide	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Silodosin	Silodosin	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error